IBOC:NASDAQInternational Bancshares Corporation Analysis
Data as of 2026-05-19 - not real-time
$72.20
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock trades above its short‑term moving averages, with the 20‑day average comfortably ahead of the 50‑day and 200‑day levels, reinforcing a bullish bias. Price remains above a well‑defined support zone and volume has been trending higher, indicating buying interest. Momentum indicators sit in a neutral‑to‑slightly‑positive range, with RSI hovering in the mid‑50s and the MACD histogram turning modestly negative, suggesting a short‑term pause but no immediate downside risk.
Fundamental backdrop: Valuation appears attractive; the price‑to‑earnings multiple is markedly lower than the sector average and discounted cash‑flow analysis points to a sizable upside potential. The company delivers solid profitability, with operating margins in the high‑60s percentile and a healthy return on equity, while maintaining a modest dividend yield supported by a low payout ratio. Analyst sentiment is strongly positive, and the balance sheet shows ample liquidity relative to debt, further underpinning the upside case.
Fundamental backdrop: Valuation appears attractive; the price‑to‑earnings multiple is markedly lower than the sector average and discounted cash‑flow analysis points to a sizable upside potential. The company delivers solid profitability, with operating margins in the high‑60s percentile and a healthy return on equity, while maintaining a modest dividend yield supported by a low payout ratio. Analyst sentiment is strongly positive, and the balance sheet shows ample liquidity relative to debt, further underpinning the upside case.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish moving‑average alignment
- Price above key support with rising volume
- Neutral momentum signals
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to peers
- Strong profitability and cash generation
- Sustainable dividend with low payout
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Consistent single‑digit revenue growth
- Low beta and moderate volatility
- Robust capital position and analyst endorsement
Key Metrics & Analysis
Financial Health
Revenue Growth5.40%
Profit Margin49.85%
P/E Ratio10.8
ROE13.51%
ROA2.52%
P/B Ratio1.4
Op. Cash Flow$471.3M
Industry P/E16.7
Technical Analysis
TrendBullish
RSI54.2
Support$70.28
Resistance$74.34
MA 20$71.90
MA 50$69.94
MA 200$69.29
MACDBearish
VolumeIncreasing
Fear & Greed Index89.61
Valuation
Fair Value$84.54
Target Price$87.00
Upside/Downside20.50%
GradeUndervalued
TypeBlend
Dividend Yield1.98%
Risk Assessment
Beta0.79
Volatility19.88%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.